Neurovascular Intervention Capabilities

Global neurovascular disease rates are escalating due to factors such obesity, high blood pressure, smoking and an aging populace. The World Stroke Organization reported around 7.6 million new cases of ischemic stroke in 2022.

TE has been a key partner to medical OEMs in the evolution of neurovascular intervention therapy devices used to treat aneurism and stroke—accessing and treating some of the most complex vasculatures of the body. Manufacturing the next generation metal-based delivery system for embolic coil delivery over two decades ago, TE continues to support medical device OEMs innovate and achieve clinical success developing neurovascular intervention therapy devices.

Given the dynamic progress in clot science, the demand for continuous innovation in neurovascular therapies remains pronounced. TE's dedicated engineering teams are collaborating closely with medical device OEMs in translating clinical requirements into pioneering technical solutions. The next generation of devices is poised to concentrate on enhanced visualization capabilities and miniaturization, aligning with industry trends.